MBX Capital is a venture capital firm that focuses on "deep health," investing in early-stage biotech and health technology companies. Their strategy involves backing science-driven innovations that tackle the root causes of chronic illnesses, often linked to environmental factors, with the goal of achieving prevention and cures through therapeutics, platform technologies, and preventative solutions.
Portfolio
3
Fund Size
$100M
Top Stage
Seed
Last 12 Mo
1
Stage Distribution
Portfolio
3 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Think Bioscience | Series A | $55M | Jan 2026 |
| Keebler Health | Seed | $6M | Feb 2025 |
| Arine | Series B | $29M | Aug 2022 |
Top Co-Investors
Underdog Labs1 shared
Hustle Fund1 shared
New Leaf Venture Partners1 shared
Katalyst Ventures1 shared
Innovation Endeavors1 shared
Janus Henderson Investors1 shared
YK Bioventures1 shared
AV8 Ventures1 shared
Buff Gold Ventures1 shared
Last updated: 3 March 2026